Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00562601 · ClinicalTrials.gov registry record

LCI Apheresis to Obtain Plasma or White Blood Cells

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Terminated
Registry status
864
Enrollment target

NCT00562601 is a clinical trial that was terminated before completion, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 864 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00562601 was terminated before completion, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

TERMINATED
Registry status
864 participants
Enrollment target

Study Summary

This study will collect blood plasma and white blood cells from individuals using a procedure called apheresis. Apheresis is a method of collecting larger quantities of certain blood components than can safely be collected through a simple blood draw or blood donation process. The blood components will be used in laboratory research studies to investigate aspects of infectious and immunologic allergic diseases. Patients 7 years of age and older who are currently enrolled in a NIH clinical research protocol may participate in this study. (Children between the ages of 2 and 6 may participate if they will benefit clinically from undergoing apheresis.) Family members of patients and normal healthy volunteers will also be enrolled. * For all adults and children weighing 55 pounds or more. Blood is drawn through a needle placed in an arm vein and circulated through a cell separator machine. The plasma and white cells are extracted, and the red cells are returned to the donor through a needle in the other arm. The procedure takes from 1 to 2 hours. * For children weighing less than 55 pounds. One unit (1 pint) of blood is drawn through a needle placed in an arm vein, similar to donating a pint of whole blood. The red blood cells are separated from the rest of the blood and returned to the donor through the same needle. This procedure requires only one needlestick and takes about 30 to 45 minutes to complete. In some circumstances, the procedure must be repeated one or more times in order to obtain large enough quantities of plasma or cells for study.

Trial Details

FieldValue
Enrollment Target 864 participants
Start Date 1988-03-28
Est. Completion 2020-01-14

What the Registry Record Tells You About NCT00562601

The ClinicalTrials.gov registry entry for NCT00562601 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 864 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00562601 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00562601 about?

NCT00562601 is a clinical study titled "LCI Apheresis to Obtain Plasma or White Blood Cells". This study will collect blood plasma and white blood cells from individuals using a procedure called apheresis. Apheresis is a method of collecting larger quantities of certain blood components than can safely be collected through a simple blood draw or blood donation process. The blood components w...

What is the current status of trial NCT00562601?

This trial is currently terminated. The enrollment target is 864 participants. The study started on 1988-03-28. Estimated completion is 2020-01-14.

Who is sponsoring clinical trial NCT00562601?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.